Skip to main content
Log in

Sentinel lymph node dissection and lymphatic mapping for local subcutaneous recurrence in melanoma treatment: Longer-term follow-up results

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Lymphatic mapping and sentinel lymph node dissection (LM/SLND) for surgical staging of cutaneous primary melanoma is currently being evaluated, but the role of these techniques in recurrent (secondary) melanoma is largely unexplored. Our experience with 12 patients indicates the potential usefulness of LM/SLND in the management of locally recurrent melanoma at subcutaneous sites. We have even used mapping to localize the sentinel node draining a subcutaneous local recurrence after previous LM/SLND for primary melanoma. The application of LM/SLND may therefore be extended beyond primary melanoma management as we understand more about the technical issues and appropriate selection of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 1992;127:392–9.

    PubMed  CAS  Google Scholar 

  2. Kollias J, Gill PG, Chatterton BE, et al. Reliability of sentinel node biopsy in predicting axillary node involvement in breast cancer.Med J Aust 1999;171:461–5.

    PubMed  CAS  Google Scholar 

  3. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymph-adenectomy for early-stage melanoma: a multicenter trial.Ann Surg 1999;230:453–63.

    Article  PubMed  CAS  Google Scholar 

  4. Uren RF, Thompson JF, Howman-Giles RB.Lymphatic Drainage of the Skin and Breast: Locating the Sentinel Nodes. Amsterdam: Harwood Academic Publishers, 1999.

    Google Scholar 

  5. Thompson JF, Uren RF, Shaw HM, et al. The location of the sentinel lymph node in cutaneous melanoma: new insights into lymphatic anatomy.J Am Coll Surg 1999;189:195–206.

    Article  PubMed  CAS  Google Scholar 

  6. Uren RF, Howman-Giles RB, Thompson JF, et al. Lymphoscin-tigraphy to identify sentinel nodes in patients with melanoma.Melanoma Res 1994;4:395–9.

    Article  PubMed  CAS  Google Scholar 

  7. Thompson JF, Uren RF, Coventry BJ, Chatterton B. Lymphoscintigraphy. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, eds.Cutaneous Melanoma. 4th ed. St. Louis: Quality Medical Publishing, 2003.

    Google Scholar 

  8. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.J Clin Oncol 2001;19:3635–48.

    PubMed  CAS  Google Scholar 

  9. Balch CM, Houghton AN, Sober AJ, Soong SJ, eds.Cutaneous Melanoma. 4th ed. St. Louis: Quality Medical Publishing, 2003: 40.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brendon J. Coventry BMBS, PhD, FRACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coventry, B.J., Chatterton, B., Whitehead, F. et al. Sentinel lymph node dissection and lymphatic mapping for local subcutaneous recurrence in melanoma treatment: Longer-term follow-up results. Annals of Surgical Oncology 11 (Suppl 3), 203S–207S (2004). https://doi.org/10.1007/BF02523629

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02523629

Key Words

Navigation